Cargando…
Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor
The coronavirus main protease, M(pro), is considered a major target for drugs suitable to combat coronavirus infections including the severe acute respiratory syndrome (SARS). In this study, comprehensive HPLC- and FRET-substrate-based screenings of various electrophilic compounds were performed to...
Autores principales: | Martina, Erika, Stiefl, Nikolaus, Degel, Björn, Schulz, Franziska, Breuning, Alexander, Schiller, Markus, Vicik, Radim, Baumann, Knut, Ziebuhr, John, Schirmeister, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127417/ https://www.ncbi.nlm.nih.gov/pubmed/16216498 http://dx.doi.org/10.1016/j.bmcl.2005.09.012 |
Ejemplares similares
-
Identification of the protease inhibitor miraziridine A in the Red sea sponge Theonella swinhoei
por: Tabares, Paula, et al.
Publicado: (2012) -
In Vitro Anticancer Activity and Mechanism of Action of an Aziridinyl Galactopyranoside
por: Burgos-Morón, Estefanía, et al.
Publicado: (2021) -
New Cysteine Protease Inhibitors: Electrophilic (Het)arenes and Unexpected Prodrug Identification for the Trypanosoma Protease Rhodesain
por: Klein, Philipp, et al.
Publicado: (2020) -
Solution-phase synthesis of 2-cyano and 2-amido aziridinyl peptides
por: Fioravanti, Stefania, et al.
Publicado: (2008) -
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
por: Previti, Santo, et al.
Publicado: (2023)